NCT05404074View on ClinicalTrials.gov

Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis

PHASE1UnknownINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 22, 2021

Primary Completion Date

October 15, 2022

Study Completion Date

October 30, 2022

Conditions
Ulcerative Colitis
Interventions
DRUG

Cobitolimod 500mg

Rectal administration

Trial Locations (1)

Unknown

RECRUITING

CTC, Clinical Trial Consultants AB, Uppsala

Sponsors
All Listed Sponsors
lead

InDex Pharmaceuticals

INDUSTRY